The drug and biotech industry had a tough time in the past couple of months after Trump announced the appointment of Robert F. Kennedy Jr., a vaccine skeptic, as the head of Health and Human ...
People with type 2 diabetes who are using Ozempic are more likely to develop damage to the optic nerve of the eye compared to those not using the popular drug, research has shown. Scientists from the ...
A new type of Aptamer Drug Conjugate (ApDC) developed by a group of Chinese researchers has recently been granted orphan drug designation from the U.S. Food and Drug Administration (FDA), bringing ...
Also Read: Eye Drug Eylea Price Manipulation: Regeneron Faces US Justice Department Allegations Over Medicare Pricing Of Its Best-Selling Eye Drug In the trial, patients treated with EYLEA HD ...
The FDA has approved Novartis’s new eye drug brolucizumab for wet age-related macular degeneration, which will match Bayer’s rival Eylea on price per dose but reduce costs with a less frequent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback